# Study of Clinical Response to Acute Metformin By Leveraging Evaluations During a Mixed Meal Tolerance Test for Exploring Glycemia and GeneticS

> **NCT02087826** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 1017 (actual)

## Conditions studied

- Genetics
- Metabolism
- Type 2 Diabetes

## Interventions

- **OTHER:** Mixed Meal Tolerance Test
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT02087826
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2014-04
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 1017 (ACTUAL)
- **Last updated:** 2026-01-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02087826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02087826, "Study of Clinical Response to Acute Metformin By Leveraging Evaluations During a Mixed Meal Tolerance Test for Exploring Glycemia and GeneticS". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02087826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*